News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
David Steensma: Fascinating to see combination trials of ruxolitinib+ reading out in myelofibrosis
Photo from David Steensma/X
Dec 1, 2023, 07:34

David Steensma: Fascinating to see combination trials of ruxolitinib+ reading out in myelofibrosis

David Steensma, Chief Medical Officer of Ajax Therapeutics, posted on X/Twitter:

“After so many years of involvement in HMA+ combination trials in MDS, it is fascinating to see combination trials of ruxolitinib+ reading out in myelofibrosis.”

Source: David Steensma/Twitter

cancer David Steensma myelofibrosis OncoDaily Oncology ruxolitinib
Special Coverage
Blog
May 9, 2025, 11:44
Susanna Fletcher Greer: A Surprising Immune Cell that could reshape how we Monitor and Mobilize Anti-Tumor Immunity
Blog
May 9, 2025, 11:43
Don S. Dizon Will Lead Sexual Health After Cancer Course at MASCC Annual Meeting
Opinion
May 9, 2025, 11:38
ASCO - Investing in Cancer Research Saves Lives!
Blog
May 9, 2025, 11:37
Manchester Cancer Research Centre Announces MB-PhD Summer Placements for Medical Students
Blog
May 9, 2025, 11:36
Chinmay Jani: Proud of Kyle Edwards for Presenting our Research Study at Sylvester Comprehensive Cancer Center
Blog
May 9, 2025, 11:28
Tanja Obradovic Highlights Ivonescimab’s Phase III Entry in Pancreatic Cancer
Blog
May 9, 2025, 11:28
Dato' Dr Saunthari Somasundaram: I’m deeply honored to be elected as the next President-Elect of the NCD Alliance
Blog
May 9, 2025, 11:22
Amer Zeidan: Honoring Two Giants in MDS at the MDSF25 Biennial Meeting
Blog
May 9, 2025, 11:20
Ruben Mesa: Great Cancer Care Starts With Great Cancer Nursing
Blog
May 9, 2025, 11:19
National Cancer Institute of Kenya Raises Awareness on Melanoma Risks and Early Detection
Blog
May 9, 2025, 11:11
Jessie Dalman: Proud of Emily Barrett for Finishing Her Time as a Chief Resident
Opinion
May 9, 2025, 11:07
Bold Leadership and Vision: Why Dr. Narjust Florez Deserves Undesignated IASLC Board Seat #4 - Florez Lab